Comerica Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Comerica Bank’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-46	Closed	-$2.7K	–	3854
2023 Q4	$2.7K	Sell	46 -1,245	-96%	-$70K	﹤0.01%	3460
2023 Q3	$56.2K	Sell	1,291 -13,228	-91%	-$472K	﹤0.01%	2667
2023 Q2	$111	Buy	+14,519	New	+$598K	0.01%	98
2022 Q1	–	Sell	-47,850	Closed	-$5.46M	–	2191
2021 Q4	$5.46M	Buy	+47,850	New	+$7.43M	0.04%	529
2021 Q2	–	Sell	-1,436	Closed	-$224K	–	2367
2021 Q1	$224K	Sell	1,436 -22	-2%	-$4.36K	﹤0.01%	2228
2020 Q4	$313K	Buy	1,458 +20	+1%	+$4.32K	﹤0.01%	2116
2020 Q3	$259K	Buy	+1,438	New	+$197K	﹤0.01%	2123

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank's MRTX Position: Q1 2024 in Review

Comerica Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 46 shares — an estimated $2.7K sold.

Comerica Bank first reported a position in MRTX in Q3 2020 and held it in 7 quarters. The position peaked at $5.46M in Q4 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Comerica Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Comerica Bank sold 46 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.7K.
Comerica Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Comerica Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $5.46M in Q4 2021.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.